Navigation Links
Ortho Clinical Diagnostics Launches VITROS 4600® Chemistry System for Mid- to High-Volume Laboratories

RARITAN, N.J., July 22, 2011 /PRNewswire/ -- Ortho Clinical Diagnostics (OCD) today announced the launch of the VITROS® 4600 Chemistry System, a state-of-the-art analyzer that delivers high-quality, reliable test results for mid- to high-volume laboratories using the same core technologies that drive reliability and efficiency throughout OCD's portfolio of products. The new analyzer completes the VITROS® x600 Family of Systems, which includes the VITROS® 5600 Integrated System and the VITROS® 3600 Immunodiagnostic System.  This portfolio of integrated instruments and broad, world-class menu of assays enable laboratories to deliver diagnostic results that help raise the standard of patient care in their institutions and networks.  

“In developing the VITROS® 4600 System, we stayed true to the value that our customers expect from OCD’s family of analyzers,” stated Holly Hillberg, Vice President, Research & Development. “The VITROS® Family of Systems provides sophisticated information management and interpretation tools that help reduce the potential for human error, improve operational efficiencies and ultimately help optimize patient care decisions.”

The VITROS® 4600 System is built on the same core VITROS® technologies that provide configurable, expandable automation solutions to streamline and standardize laboratory workflow while enhancing throughput. The proprietary technologies that drive this reliability and efficiency include:

  • MicroSlide Technology - allows for system operation independent of water supply and drainage and delivers high-quality results with 95 percent reportable result efficiency, minimizing operator interventions and maximizing ease of use.
  • MicroTip Technology - provides special chemistry menu offerings and user-defined assays in a format that is cost-effective and easy to implement with a low risk of carryover.
  • MicroSensor Technology - boosts efficiency and controls costs by automatically detecting and flagging issues with patient samples without compromising turnaround time or operator workflow.
  • Intellicheck™ Technology - delivers real-time process monitoring with fully documented traceability to minimize the risk of erroneous result reporting.
  • e-Connectivity® Interactive System Management - offers real-time access to information for proactive diagnosis and remote repair, maximizing uptime and increasing staff productivity.

Further, the automation-ready, point-in-space interface of the new system provides the flexibility to standardize and consolidate testing by combining the VITROS® 3600 Immunodiagnostic System and the VITROS® 5600 Integrated System on the enGen™ Laboratory Automation System.  

“The VITROS® 4600 System was developed to provide test results that laboratories and patients can count on, while optimizing staffing, supporting standardized practices and managing total operating costs,” said Peter Hoehn, Vice President, Worldwide Marketing, Clinical Laboratories.  “The design of this system is a result of actively listening and responding to the needs of our customers by investing in products, services and process solutions that meet the unique needs of modern clinical laboratories.”

As part of its commitment to customers, OCD also provides access to crucial services and solutions that help make labs more efficient in delivering the quality results doctors and patients need. 

  • To maximize uptime, OCD's industry-leading Remote Monitoring Center (RMC) - the first-of-its-kind 24 hours / 7 days a week central command center in the in vitro diagnostic industry - is designed to proactively determine the need for certain preventative intervention thus maximizing operational uptime. 
  • OCD's ValuMetrix® Services is an international strategic consulting and training service that helps healthcare organizations increase capacity, eliminate waste, and implement LEAN principles to optimize the efficiency of their operations.
  • ORTHO PLUS(SM) Inventory Management is an online service to help U.S. customers reduce manual inventory activities and lower costs by recording usage and automatically generating reorder recommendations for review by lab managers.

About the VITROS® 4600 Chemistry System

The VITROS® 4600 Chemistry System is Ortho Clinical Diagnostics' most recent addition to the VITROS® x600 family of analyzers.  It offers standardized, high quality test results using common technologies across our continuum of integrated and stand-alone systems. Beginning with dry slide technology, the VITROS® 4600 System leverages OCD's core technologies that maximize patient result quality and promote ease of use and productivity. Key features of the VITROS® 4600 Chemistry System include an intuitive, easy-to-use graphical user interface that is standardized across our family of analyzers; disposable tip metering; up to 6-month calibration stability; parallel processing of routine and special tests for uncompromised workflow; reduced maintenance requirements, adjustable thresholds for onboard inventory management and calibration expiration.  The VITROS® 4600 Chemistry System also incorporates state-of-the-art features including MicroSlide Technology, MicroTip Technology, MicroSensor Technology, Intellicheck™ Technology and e-Connectivity® Interactive System Management.  In addition, the VITROS® 4600 Chemistry System provides a comprehensive chemistry menu including therapeutic drugs, special proteins, and DAT/Toxicology.

About Ortho Clinical Diagnostics

Ortho-Clinical Diagnostics, Inc. delivers the high-quality in vitro diagnostic products that give healthcare professionals around the world the knowledge they need to make better treatment decisions sooner.  The company serves the global transfusion medicine community with donor screening and blood typing products to help ensure every patient receives blood that is safe, the right type and the right unit.  Ortho Clinical Diagnostics also brings sophisticated information management, testing technologies, and automation and interpretation tools to clinical laboratories worldwide to help them run more efficiently and improve patient care.  For more information, visit

SOURCE Ortho-Clinical Diagnostics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Orthopaedics: Market Prospects & Global Competition
2. Daiichi Sankyo Launches LIXIANA® (edoxaban), a Direct Oral Factor Xa Inhibitor, in Japan for the Prevention of Venous Thromboembolism after Major Orthopedic Surgery
3. Valeant Pharmaceuticals Agrees to Acquire Ortho Dermatologics
4. Janssen Pharmaceuticals, Inc. Announces Definitive Agreement to Divest Ortho Dermatologics Division
5. Hanger Orthopedic Group, Inc. Announces Second Quarter 2011 Earnings Release Conference Call
6. Ascension Orthopedics Announces Market Release of TITAN™ Inset Mini Glenoid
7. Ascension Orthopedics Implants PyroTITAN™ in Geelong, Australia
8. MiMedx Group Receives FDA Clearance to Market Its HydroFix™ Ortho Shield™ Device
9. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of RISPERDAL® Tablets and One Lot of Risperidone Tablets
10. Orthopedics This Week Now on Bloomberg
11. ORTHOCON®, Inc. Receives 510(k) Clearance to Market HEMASORB Apply™
Post Your Comments:
(Date:10/13/2015)... N.C. , Oct. 13, 2015  Yesterday Congresswoman ... Influenza Vaccines Holly Springs manufacturing site located in ... 2014, the facility has produced Flucelvax ® (Influenza ... the potential for faster start-up and is not reliant ... CSL Limited acquired the influenza vaccines business of Novartis ...
(Date:10/12/2015)... 12, 2015 Given the intricacy of ... challenging to deliver an ophthalmic drug effectively to a specific ... successful ocular drug delivery. These include dilution of a drug ... of conjunctiva and drug permeation issues with respect to the ... topical eye drops, is lost due to the aforementioned barriers. ...
(Date:10/12/2015)... CRANBURY, N.J. , Oct. 12, 2015 /PRNewswire/ ... that a securities fraud class action complaint was ... of New Jersey.  The complaint alleges that officers and ... Securities Exchange Act of 1934 between September 15, 2015 ... misleading statements about Amicus Therapeutics, business prospects.  Amicus is ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... October 13, 2015 , ... ... kind product that targets the unique health needs of new moms. Postnatal ... Pregnancy Association ( ), utilizes Nordic Naturals’ exclusive, new, ultra-concentrated omega-3 ...
(Date:10/13/2015)... ... 2015 , ... California Southern University has named Dr. Judith ... Doctor of Nursing Practice from the renowned Johns Hopkins University—comes to CalSouthern with ... McLeod’s long and successful nursing practice included a variety of patient care, education ...
(Date:10/13/2015)... , ... October 13, 2015 , ... ... Bill Saye as the newest professional to introduce the latest development, ThermiVa® temperature ... recognized as a leading professional in Obstetrics and Gynecology and a pioneer in ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... home furnishings and décor, today announced it closed on a $20.5 million funding ... will be used to support the Company’s continued rapid growth and expansion, broaden ...
(Date:10/13/2015)... ... 2015 , ... The Bill Howe Family of Companies is an award winning ... flood remediation services. Family-owned and operated for 35 years, they have maintained value, ethics ... plumber two years in a row from the Union Tribune Reader’s Poll, a Healthiest ...
Breaking Medicine News(10 mins):